Pill refused combination colour-shape mark

In Astrazeneca AB v Novopharm Ltd, the Federal Court of Appeal
has ruled that "a yellow colour applied to the whole of the visible surface
of a round tablet" containing a blood pressure medication is not sufficiently
distinctive to be registrable as a trademark because there are numerous other
round, yellow tablets sold in Canada for the same ailment.